Walleye Capital
MGNX icon

Walleye Capital’s MacroGenics MGNX Stock Holding History

Walleye Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289 Buy
+100
New +$213 ﹤0.01% 4280

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Walleye Capital's MGNX Position: Q1 2026 in Review

Walleye Capital increased its MacroGenics (MGNX) stake by 910% in Q1 2026, buying an estimated $644K and bringing the position to 335,265 shares worth $969K. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Walleye Capital first reported a position in MGNX in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.89M in Q1 2022. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Walleye Capital held 335,265 shares of MacroGenics worth $969K as of Q1 2026.
  • Walleye Capital bought 302,085 MacroGenics shares in Q1 2026, an estimated $644K.
  • MacroGenics made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2105 holding.
  • Walleye Capital first reported a position in MacroGenics in Q1 2022 and has held it in 12 quarters since.
  • Walleye Capital's MacroGenics position peaked at $1.89M in Q1 2022.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.